Case study: patient-derived clear cell adenocarcinoma xenograft model longitudinally predicts treatment response

There has been little progress in the use of patient-derived xenografts (PDX) to guide individual therapeutic strategies. In part, this can be attributed to the operational challenges of effecting successful engraftment and testing multiple candidate drugs in a clinically workable timeframe. It also...

Descripción completa

Detalles Bibliográficos
Autores principales: Vargas, Roberto, Gopal, Priyanka, Kuzmishin, Gwendolyn B., DeBernardo, Robert, Koyfman, Shlomo A., Jha, Babal K., Mian, Omar Y., Scott, Jacob, Adams, Drew J., Peacock, Craig D., Abazeed, Mohamed E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041303/
https://www.ncbi.nlm.nih.gov/pubmed/30202792
http://dx.doi.org/10.1038/s41698-018-0060-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041303/
https://www.ncbi.nlm.nih.gov/pubmed/30202792
http://dx.doi.org/10.1038/s41698-018-0060-3

Ejemplares similares